Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
NCCN Guidelines for Patients
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
CLL Society
NCCN COVID-19 Resources Page